Inhibition of BCR-ABL activity in primary CD34+ CML cells resulted in significant upregulation of Hes1. Hes1 functions as a transcriptional repressor by interacting with histone deacetylase HDAC1 [40,41]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.